Download presentation
Presentation is loading. Please wait.
1
Volume 12, Issue 6, Pages 644-647 (June 2013)
Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment Chris Mason, Julian Mason, Emily J. Culme-Seymour, Gregory A. Bonfiglio, Brock C. Reeve Cell Stem Cell Volume 12, Issue 6, Pages (June 2013) DOI: /j.stem Copyright © 2013 Elsevier Inc. Terms and Conditions
2
Figure 1 Cell Therapy Index for Q4 2012 and Q1 2013
The index is composed of cell therapy companies with market capitalizations greater than $50M. It commences on October 1, 2012 with a benchmark value set at 1,000. The major established biotechnology indices (BTK and NBI) are included and demonstrate that the cell therapy industry is a unique investment class and thus distinct from biotech. See also Table S1. Cell Stem Cell , DOI: ( /j.stem ) Copyright © 2013 Elsevier Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.